Comparative effects of a novel Vitamin D Analogue MC-903 and 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity, osteocalcin and DNA synthesis by human osteoblastic cells in culture
- 1 January 1990
- Vol. 11 (3), 171-179
- https://doi.org/10.1016/8756-3282(90)90211-g
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind studyBritish Journal of Dermatology, 1988
- Characterization of endosteal osteoblastic cells isolated from mouse caudal vertebraeBone, 1988
- Effects of bone associated growth factors on dna, collagen and osteocalcin synthesis in cultured fetal rat calvariaeBone, 1988
- Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro.The Journal of cell biology, 1987
- Transforming growth factor-β reduces the phenotypic expression of osteoblastic MP3T3-E1 cells in monolayer cultureBone, 1987
- Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoidsMetabolic Bone Disease and Related Research, 1984
- Binding of 1,25‐dihydroxy‐[3H]vitamin D3 in nuclear and cytosol fractions of whole mouse skin in vivo and in vitroFEBS Letters, 1981
- A Specific High-Affinity Binding Macromolecule for 1,25-Dihydroxyvitamin D 3 in Fetal BoneScience, 1977
- 1,25-Dihydroxycholecalciferol and Parathormone: Effects on Isolated Osteoclast-Like and Osteoblast-Like CellsScience, 1977
- 1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue CultureScience, 1972